Host factors and failure of interferon-α treatment in hepatitis C virus
Open Access
- 25 March 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 39 (4) , 880-890
- https://doi.org/10.1002/hep.20139
Abstract
Failure of interferon-α (IFN-α) treatment in patients with chronic hepatitis C virus (HCV) infection is a challenging obstacle for clinical and experimental hepatology. Both viral and host factors have been implicated in reducing responsiveness to IFN-α therapy. The role of viral factors has been studied extensively and has been summarized in several review articles; however, much less attention has been paid to host factors. In this paper, we review evidence of host factor involvement in IFN-α treatment failure. We discuss possible underlying mechanisms responsible for these effects. Potential therapeutic strategies to enhance the effectiveness of IFN-α therapy for HCV are also proposed. (Hepatology 2004;39:880ndash;890.)Keywords
This publication has 108 references indexed in Scilit:
- Viral Dynamics and Response Differences in Hcv–Infected African American and White Patients Treated With Ifn and RibavirinHepatology, 2003
- Hepatitis viruses and the MAPK pathway: is this a survival strategy?Virus Research, 2003
- Hepatitis C and AlcoholJournal of Clinical Gastroenterology, 2003
- Polymorphisms in the interleukin-10, tumor necrosis factor-α, and transforming growth factor-β1 genes in chronic hepatitis C patients treated with interferon and ribavirinJournal of Hepatology, 2002
- IL‐10 attenuates IFN‐α‐activated STAT1 in the liver: involvement of SOCS2 and SOCS3FEBS Letters, 2000
- The α Chemokine, Interleukin 8, Inhibits the Antiviral Action of Interferon αThe Journal of Experimental Medicine, 1997
- Quasispecies nature of hepatitis C virus and response to alpha interferon: significance as a predictor of direct response to interferonJournal of Hepatology, 1997
- Changes in Blood Lipid Composition and Response to Interferon Treatment in Chronic Hepatitis CJournal of Interferon & Cytokine Research, 1995
- Clinical predictors of response to recombinant interferon‐α treatment in patients with chronic non‐A, non‐B hepatitis (hepatitis C)Journal of Viral Hepatitis, 1994
- α- and γ-interferon versus α-interferon alone in chronic hepatitis B: A randomized controlled studyJournal of Hepatology, 1993